Methylene blue inhibits replication of SARS-CoV-2 in vitro

In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus diseases 2019 (COVID-19) emerged in Wuhan, China. Currently there is no antiviral treatment recommended against SARS-CoV-2. Identifying effective antiviral drugs is urgently requi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Antimicrob Agents
Autors principals: Gendrot, Mathieu, Andreani, Julien, Duflot, Isabelle, Boxberger, Manon, Le Bideau, Marion, Mosnier, Joel, Jardot, Priscilla, Fonta, Isabelle, Rolland, Clara, Bogreau, Hervé, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566888/
https://ncbi.nlm.nih.gov/pubmed/33075512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106202
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars